What Do CEL, BLK, ABCC8, and KCNJ11 Results Mean in MODY?

While most people with MODY (Maturity-Onset Diabetes of the Young) have genetic changes in the GCK, HNF1A, or HNF4A genes, genetic testing sometimes reveals a variant in a rarer gene ^{[1] [2]}. If your report lists a rare subtype like MODY 8 (CEL), MODY 11 (BLK), MODY 12 (ABCC8), or MODY 13 (KCNJ11), your care plan will be highly individualized.

Receiving a rare genetic result can be confusing, but a result does not automatically mean severe disease or an immediate medication change. Because these subtypes behave differently than common forms of MODY, standard care may need to be adapted after an expert review by an endocrinologist who specializes in monogenic diabetes (diabetes caused by a single gene) ^{[3] [4]}. Your usual diabetes care—including routine blood sugar monitoring, A1c checks, and eye or kidney evaluations—remains just as important ^[1].

Understanding Your Genetic Report: Pathogenic vs. VUS

Before making any changes to your care, a specialist must verify exactly what your genetic report says. Genetic changes are often classified into categories:

• Pathogenic or Likely Pathogenic: The change is known or highly suspected to cause disease ^[4].
• Variant of Uncertain Significance (VUS): There is not enough evidence to know if this specific gene change causes diabetes or if it is just a harmless variation ^[5].

Important Safety Rule: A VUS should never be used on its own to change your medication, diagnose you with MODY, or trigger genetic testing for your family ^{[5] [4]}.

Understanding the Rare Subtypes

CEL (MODY 8): The Exocrine and Endocrine Subtype

The CEL gene provides instructions for making a digestive enzyme that helps your body break down and absorb dietary fats ^[6]. Unlike most forms of diabetes, MODY 8 can involve both the endocrine pancreas (which makes insulin) and the exocrine pancreas (which makes digestive enzymes) ^{[3] [7]}.

• What to expect: Some people with pathogenic CEL variants develop exocrine pancreatic dysfunction before diabetes ^[3]. This can cause fat malabsorption or digestive symptoms. While structural changes like pancreatic shrinkage (pancreatic atrophy), cysts, or chronic pancreatitis are possible, they do not happen to everyone ^{[3] [7]}.
• Management: The diabetes typically progresses to require insulin eventually ^[3]. Because of the exocrine risk, a specialist will individualize monitoring of your pancreas and nutrition. They may test your stool for fecal elastase (a marker of digestive enzymes) to see if you need enzyme replacement therapy ^{[8] [3]}.

ABCC8 and KCNJ11: The Potassium Channel Types

The ABCC8 and KCNJ11 genes help build the ATP-sensitive potassium channel (KATP channel) on the surface of your beta cells (the pancreas cells that release insulin) ^[1]. These genes are also known for causing neonatal (newborn) diabetes ^[9].

• What to expect: The effects depend entirely on the exact genetic variant you have. Some variants are “activating” (gain-of-function) and cause diabetes ^[10]. Other variants are “loss-of-function” and can actually cause too much insulin production (hyperinsulinism) ^[10]. Severity varies widely, and patients are sometimes initially misdiagnosed with Type 1 or Type 2 diabetes ^{[9] [11]}.
• Management: For specific diabetes-causing variants, the altered channel may respond well to oral sulfonylureas (a medication that targets this specific channel) ^{[1] [12]}. Some people can successfully switch from insulin to sulfonylureas ^{[13] [14]}. However, response is variable, and some patients absolutely still need insulin ^{[15] [16]}.

BLK (MODY 11): A Debated Association

If your report lists BLK (often historically called MODY 11), it is crucial to seek a second opinion.

• What to expect: Large-scale genetic studies have found that BLK variants are common in the general population and do not consistently cause diabetes ^{[5] [17]}. The scientific community now strongly debates or considers this association unconfirmed ^[5].
• Management: Because of this lack of evidence, a BLK finding should not be assumed to be the cause of your diabetes ^{[5] [18]}. A specialist will likely recommend continuing standard care while looking for alternative causes, like Type 1 or Type 2 diabetes.

Before Changing Treatment: A Safety Checklist

If you receive a rare MODY diagnosis, do not stop or reduce your insulin on your own ^[16]. Any transition must be strictly supervised by a specialist.

• Keep taking your currently prescribed medications ^[1].
• Bring your complete genetic laboratory report to your appointment, noting the exact variant and its classification (Pathogenic vs. VUS) ^[4].
• Discuss a safe transition plan. If a medication switch is attempted (such as with ABCC8/KCNJ11), it requires close blood glucose and ketone monitoring, as well as clear instructions on how to handle severe high blood sugars or hypoglycemia (low blood sugar) ^[13].
• Seek urgent medical advice for persistent high glucose, positive ketones, vomiting, or dehydration ^[15].

Family Testing

Because monogenic diabetes is inherited, a confirmed pathogenic variant may mean your first-degree relatives (parents, siblings, children) could share the trait. A specialist or genetic counselor can discuss cascade testing (systematically testing family members for the exact known variant) ^[19]. Remember, relatives should generally not be tested for a VUS ^[5].